WHO Approves First Malaria Drug Made for Newborns

Establishment-critical narrative

Headlines tied to Gates Foundation efforts warrant skepticism, as reality often falls short. Gates was part of a successful malaria vaccine effort decades ago, but cut funding for it despite reducing severe cases by a third, redirecting money toward new initiatives instead of scaling what worked. Since then, billions have continued to flow through the WHO and allied groups, blurring philanthropy and influence. Calling this a public health triumph ignores who controls the money and who benefits.